Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.99 USD | -1.96% | +9.11% | -7.13% |
04-16 | Foghorn Therapeutics Names Kristian Humer CFO | MT |
04-16 | Foghorn Therapeutics Inc. Appoints Kristian Humer as Chief Financial Officer | CI |
Evolution of the average Target Price on Foghorn Therapeutics Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Foghorn Therapeutics Inc.
Morgan Stanley | |
Goldman Sachs | |
Wedbush | |
HC Wainwright | |
BMO Capital | |
BofA Securities |
EPS Revisions
- Stock Market
- Equities
- FHTX Stock
- Consensus Foghorn Therapeutics Inc.